MFG
HAE icon

Mendota Financial Group’s Haemonetics HAE Stock Holding History

Mendota Financial Group’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,448
Closed -$91.5K – 337
2023
Q1 		$91.5K Buy
+1,448
New +$117K 0.09% 100

Other funds holding HAE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Mendota Financial Group's HAE Position: Q2 2023 in Review

Mendota Financial Group sold out of Haemonetics (HAE) in Q2 2023, closing a stake of 1,448 shares — an estimated $91.5K sold.

Mendota Financial Group first reported a position in HAE in Q1 2023 and held it in 1 quarter. The position peaked at $91.5K in Q1 2023. 296 funds tracked by Wall St. Rank hold HAE as of Q2 2023.

  • Mendota Financial Group reported no remaining Haemonetics position as of Q2 2023 after selling out during the quarter.
  • Mendota Financial Group sold 1,448 Haemonetics shares in Q2 2023, an estimated $91.5K.
  • Mendota Financial Group first reported a position in Haemonetics in Q1 2023 and held it in 1 quarter.
  • Mendota Financial Group's Haemonetics position peaked at $91.5K in Q1 2023.
  • 296 funds tracked by Wall St. Rank held Haemonetics as of Q2 2023.

Based on Mendota Financial Group's 13F filing for Q2 2023, filed 25 Jul 2023.